We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$10.7B
AUM Growth
+$2.52B
(+31%)
Cap. Flow
+$2.21B
Cap. Flow
% of AUM
20.71%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$119M |
| 2 |
Perrigo
PRGO
|
+$108M |
| 3 |
Microsoft
MSFT
|
+$107M |
| 4 |
Zoetis
ZTS
|
+$84.7M |
| 5 |
Viatris
VTRS
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$73.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$66.6M |
| 4 |
Nike
NKE
|
+$57.9M |
| 5 |
AutoZone
AZO
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.92% |
| 2 | Communication Services | 13.85% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 12.2% |
| 5 | Consumer Discretionary | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
ASML
ASML
$669B
| $360K | ﹤0.01% |
+4,050
| New | +$369K |
|
|
ERF
852
DELISTED
Enerplus Corporation
ERF
| $357K | ﹤0.01% |
+104,251
| New | +$498K |
|
|
KAMN
853
DELISTED
Kaman Corp
KAMN
| $357K | ﹤0.01% |
8,751
-33,183
| -79% | -$1.3M |
|
854
Unilever
UL
$136B
| $354K | ﹤0.01% |
+7,299
| New | +$356K |
|
|
TIVO
855
DELISTED
Tivo Inc
TIVO
| $354K | ﹤0.01% |
+21,272
| New | +$239K |
|
856
Lesaka Technologies
LSAK
$420M
| $350K | ﹤0.01% |
+25,880
| New | +$406K |
|
857
PepsiCo
PEP
$190B
| $350K | ﹤0.01% |
3,503
-66,251
| -95% | -$6.61M |
|
858
Nabors Industries
NBR
$1.21B
| $347K | ﹤0.01% |
817
+429
| +111% | +$211K |
|
|
SNCR
859
DELISTED
Synchronoss Technologies
SNCR
| $343K | ﹤0.01% |
+1,082
| New | +$359K |
|
860
MGM Resorts International
MGM
$11.2B
| $339K | ﹤0.01% |
14,914
-184,638
| -93% | -$4.07M |
|
|
SN
861
DELISTED
Sanchez Energy Corporation
SN
| $336K | ﹤0.01% |
+78,070
| New | +$441K |
|
862
Duluth Holdings
DLTH
$159M
| $332K | ﹤0.01% |
+22,739
| New | +$343K |
|
863
Matsons
MATX
$6.18B
| $327K | ﹤0.01% |
7,675
-40,615
| -84% | -$1.89M |
|
864
FreightCar America
RAIL
$260M
| $326K | ﹤0.01% |
+16,781
| New | +$353K |
|
865
Regeneron Pharmaceuticals
REGN
$80.8B
| $322K | ﹤0.01% |
594
-14,528
| -96% | -$7.87M |
|
866
Methanex
MEOH
$4.12B
| $321K | ﹤0.01% |
9,734
+106
| +1% | +$4.05K |
|
|
BNFT
867
DELISTED
Benefitfocus, Inc.
BNFT
| $316K | ﹤0.01% |
+8,690
| New | +$308K |
|
|
PMC
868
DELISTED
PharMerica Corporation
PMC
| $313K | ﹤0.01% |
+8,940
| New | +$280K |
|
869
United Therapeutics
UTHR
$23.1B
| $311K | ﹤0.01% |
1,987
-123,530
| -98% | -$18M |
|
|
MTBL
870
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
| $309K | ﹤0.01% |
+55,901
| New | +$296K |
|
|
SIRO
871
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $306K | ﹤0.01% |
2,789
-24,907
| -90% | -$2.67M |
|
872
XPO
XPO
$23.7B
| $300K | ﹤0.01% |
+31,852
| New | +$316K |
|
|
ELGX
873
DELISTED
Endologix Inc
ELGX
| $299K | ﹤0.01% |
+3,017
| New | +$323K |
|
874
Liberty Latin America Class C
LILAK
$1.64B
| $297K | ﹤0.01% |
+8,061
| New | +$263K |
|
875
Trip.com Group
TCOM
$29.1B
| $297K | ﹤0.01% |
6,407
-22,789
| -78% | -$1.04M |
|
Similar funds
Marshall Wace's Q4 2015 Portfolio in Review
As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.
- Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
- Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
- Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
- Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
- Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
- Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
- Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.
Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.